Tag: Cancer: Uterine
Moderate, Heavy Use of Chemical Hair Relaxer Linked to Uterine Cancer
Among postmenopausal women, moderate and heavy use associated with increased risk versus never/light use
Selinexor Increases PFS for Endometrial Cancer With TP53 Mutations
Findings seen for maintenance therapy in patients with advanced or recurrent disease following response to systemic therapy
Rates of Endometrial Cancer Vary for U.S., Caribbean Black Women
Caribbean Black women have lowest rates of endometrioid and nonendometrioid subtypes
Adding Dostarlimab Improves Progression-Free Survival in Endometrial Cancer
Dostarlimab plus carboplatin-paclitaxel linked to increased progression-free survival overall and in dMMR-MSI-H population
Adding Pembrolizumab to Chemo Improves Survival in Endometrial Cancer
Addition of pembrolizumab to paclitaxel plus carboplatin yields longer progression-free survival in advanced, recurrent disease
Acupuncture, Acupressure Beneficial in Gynecologic Cancer Surgery Setting
Improvement seen in severe pain, anxiety for treatment groups receiving preoperative touch/relaxation with or without intraoperative acupuncture
Recommendations Updated for Radiation Therapy in Endometrial Cancer
Radiation therapy recommended to reduce risk for vaginal and/or pelvic recurrence; data limited for sequencing radiation therapy and chemo
Risk of Uterine Diseases, Cancers Up With Tamoxifen Treatment
After adjustment for confounding variables, risk of endometrial cancer was increased almost fourfold with tamoxifen treatment
Woman Sues L’Oreal Over Claim Hair Straightener Spurred Uterine Cancer
Lawsuit comes on the heels of a study that revealed increased risk for uterine cancer in women who use chemical hair-straightening products
Hair Straightening Product Use Linked to Uterine Cancer
Association stronger when comparing frequent use in the past 12 months with never use
